Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2016

Winer A, Janosky M, Harrison B, Zhong J, Moussai D, Siyah P, et al. Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study. Mol Cancer Ther. 2016;15(10):2370-2377.

Noy A, Lensing SY, Moore PC, Gupta N, Aboulafia D, Ambinder R, et al. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leuk Lymphoma. 2016;57(7):1731-4.

Eelen G, Verlinden L, Maes C, Beullens I, Gysemans C, Paik J-, et al. Forkhead box O transcription factors in chondrocytes regulate endochondral bone formation. J Steroid Biochem Mol Biol. 2016;164:337-343.

Geyer JT, Orazi A. Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnostic principles and upcoming updates. Int J Lab Hematol. 2016;38 Suppl 1:12-9.

Mullane SA, Werner L, Guancial EA, Lis RT, Stack EC, Loda M, et al. Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma. Clin Genitourin Cancer. 2016;14(4):352-9.

Cantalupo A, Di Lorenzo A. S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis. J Pharmacol Exp Ther. 2016;358(2):359-70.

Testo N, Olson LC, Subramaniyam S, Hanson T, Magro CM. Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas. Am J Dermatopathol. 2016;38(10):769-74.

Arnold AR, Burnham C-, Ford BA, Lawhon SD, McAllister SK, Lonsway D, et al. Evaluation of an Immunochromatographic Assay for Rapid Detection of Penicillin-Binding Protein 2a in Human and Animal Staphylococcus intermedius Group, Staphylococcus lugdunensis, and Staphylococcus schleiferi Clinical Isolates. J Clin Microbiol. 2016;54(3):745-8.

Crowley MJ, Scognamiglio T, Liu Y-, Kleiman DA, Beninato T, Aronova A, et al. Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma. J Clin Endocrinol Metab. 2016;101(3):981-7.

Loda M. Challenging Roadblocks to Cancer Cure. Cancer Res. 2016;76(17):4924-30.